AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05779137 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: MBCT
Description: Patients will join a mindfulness-based cognitive therapy course at the Radboudumc Center for Mindfulness. The course consists of eight weekly sessions of 2.5-hour and one 6-hour silence day between the 6th and 7th session. The sessions include meditation exercises (body-scan, sitting meditation, gentle movement exercises, three-minute breathing space, daily activities with attention), psychoeducation and group discussion. Psychoeducation includes information on cognitive techniques, like monitoring and scheduling of events and identification of negative automatic thoughts. In addition, all participants will be encouraged to perform daily practice assignments at home for about 30-45 minutes per day, mainly consisting of meditation exercises.
Study NCT05791500 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: lifestyle intervention
Description: dietary behavior interventions:through a couple of dietary health education lectures physical activity interventions:through at least an offline teaching and jump rope or jog regularly and quantitatively life schedule and habits intervention group: live in a regular and healthy life habit and last at least 4 months
Study NCT04754698 — intervention group
Intervention type: BIOLOGICAL
Group type: OTHER
Intervention: CoronaVac
Description: CoronaVac (Sinovac Biotech Ltd., Beijing, China)
Study NCT06540781 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: wet cupping therapy
Description: The cupping (WCT) procedure consists of five phases:~Primary suction: Using a manual suction pump, air was drawn from glass cups that were positioned on the chosen locations. The skin and subcutaneous tissue swelled as a result of the cups' five minutes of skin contact.~Area disinfection: After disinfecting the cupped areas with povidone-iodine, they were wiped with sterile gauze.~Scarification: Using a sterile number 11 surgical blade, superficial incisions measuring 20-30 gauge in length and 1-2 mm in depth were made on the skin.~Bloodletting and secondary suction: Once again applied to the scarified areas, the previously removed cups created suction using the manual pump which was previously mentioned. In order to fill the cups, blood was drawn from the skin's and subcutaneous tissue's capillaries.~Removing and dressing: After 10 minutes, the cups filled with blood were removed. The application areas were wiped with sterile gauze, and dressings were applied.
Study NCT06223659 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Eutectic Mixture of Local Anesthetics
Description: Apply topically to skin
Study NCT06223659 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Administration
Description: Apply topically to skin
Study NCT06223659 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Questionnaire Administration
Description: Ancillary studies
Study NCT06223659 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Questionnaire Administration
Description: Ancillary studies
Study NCT06355765 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Intervention: Citicoline blackcurrant supplement
Description: Citicoline, Vitamins A, B, C and E, and Blackcurrant
Study NCT06208787 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Neurofeedback training
Description: Neurofeedback training involving auditory feedback upon measurement of non-harmonic alpha-theta ratios during focused attention meditation
Study NCT06208787 — intervention group
Intervention type: BEHAVIORAL
Group type: SHAM_COMPARATOR
Intervention: Sham Training
Description: Sham neurofeedback involving auditory feedback at random timepoints during focused attention meditation such that no learning can take place
Study NCT05972200 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Active HD-tDCS over V5/MT
Description: For HD-tDCS a 4 × 1 montage (Kessler et al., 2013), small circular electrodes (diameter 1 cm) will be used with the anode placed centrally with a current intensity of 1 mA for a total of 20 minutes (30 s ramp up/down). Hereby, the anodal electrode modulates the excitability of the targeted area left V5/MT, whereas the other 4 electrodes return electrical currents that flow away from that area. V5/MT will be localised via published procedures and electrode's placement will be done according to the 10-20 International EEG 10-20 System for electrode placement.
Study NCT05972200 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Active HD-tDCS over V1
Description: For HD-tDCS a 4 × 1 montage (Kessler et al., 2013), small circular electrodes (diameter 1 cm) will be used with the anode placed centrally with a current intensity of 1 mA for a total of 20 minutes (30 s ramp up/down). Hereby, the anodal electrode modulates the excitability of the targeted area left V1, whereas the other 4 electrodes return electrical currents that flow away from that area. V1 will be localised via published procedures and electrode's placement will be done according to the 10-20 International EEG 10-20 System for electrode placement.
Study NCT05972200 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Sham HD-tDCS over V5/MT or V1
Description: Sham HD-tDCS will be delivered over left V5/MT or left V1. The same electrodes placement as well as the stimulation set-up will be used as in the active stimulation conditions, but the current will be applied for 30 s and will be ramped down (0 mA) during the rest of the session without the participants awareness. .
Study NCT05706896 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Intravitreal injection of CB-PRP
Description: The procedure consists in a trans-scleral puncture to access the vitreous cavity, with subsequent injection of CB-PRP
Study NCT04729985 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: CGM device with diabetic education, CGM education and a follow up protocol.
Description: Blind CGM placed and recorded for 14 days after discharge and data downloaded
Study NCT05908682 — intervention group
Intervention type: OTHER
Intervention: Non-interventional study
Description: This is not an interventional study
Study NCT06450652 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Chinese Herbal Medicine granules
Description: The intervention will be a 4 weeks of Chinese Herbal Medicine (CHM) granules, which will consist of six Chinese herbs. Subjects will take one sachet orally, twice daily after meals for 4 weeks. Way of taking CHM granules is as follow: Add 100ml boiling water into a cup, then pour one pack of granules into the cup and soap it for 2-3 mins. Stir until the granules completely dissolve before drinking.
Study NCT05376865 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Vitamin D supplement
Description: The intervention group receives 50000 IU of vitamin D every week as vitamin D supplements for 12 weeks, provided monthly.
Study NCT05376865 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Vitamin D supplement
Description: The intervention group receives 50000 IU of vitamin D every week as vitamin D supplements for 12 weeks, provided monthly.
Study NCT05939310 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Fluorescence guided detection of tumor positive margins.
Description: Intraoperative fluorescence imaging detection of tumor positive margins using the targeted tracer bevacizumab-IRDye800CW.
Study NCT05479942 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Graded motor imagery training paradigm
Description: Graded motor imagery is the psychological representation of attention doing movement of a part of body, without actually moving that part, it broken down into three unique stages of treatment techniques:~1. Left/right discrimination (Implicit motor imagery):~2. Explicit motor imagery~3. Mirror Therapy
Study NCT05479942 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: conventional therapy (task-oriented active/passive range of motion training)
Description: Patient will do 3 tasks as: drinking water from a glass, lifting a glass of water to a level of 90° shoulder flexion with an extended elbow, moving 5 crystals from the table to a box, wiping the table with a towel with the elbow extended, grasping and releasing a 6 cm in diameter tennis ball, and combing their hairs.~Practice shoulder flexion and abduction active ROM, and passive ROM training
Study NCT05312177 — intervention group
Intervention type: OTHER
Intervention: Stanford Binet Intelligence Scales, Fifth Edition
Description: The SB-5 is a comprehensive measure of cognitive and intellectual functioning for individuals from age two through 85 years of age. The SB-5 individually assess a child's functioning in five areas of cognitive functioning: Fluid Reasoning, Knowledge, Quantitative Reasoning, Visual Spatial, and Working Memory. The SB-5 is well established in the existing research literature as an assessment tool to evaluate developmental and intellectual abilities in children with ND disorders.
Study NCT05312177 — intervention group
Intervention type: OTHER
Intervention: Vineland Adaptive Behavior Scales Third Edition
Description: The VABS-3 are a parent report, interview style measure of adaptive behavior for individuals ages birth through 90 months. The VABS-3 assesses adaptive behavior in four broad domains of Communication, Daily Living Skills, Socialization, and Motor Skills, and includes a Maladaptive Behavior Domain that assesses problem behaviors.
Study NCT05312177 — intervention group
Intervention type: OTHER
Intervention: Peabody Picture Vocabulary Test, Fifth Edition
Description: The PPVT-5 is a norm-referenced language measure that evaluates single-word receptive vocabulary. The PPVT-5 provides standard scores for individuals ages 2.6 through 90 years.
Study NCT05312177 — intervention group
Intervention type: OTHER
Intervention: Expressive Vocabulary Test, Third Edition
Description: The EVT-3 is a norm-referenced language measure that evaluates single-word expressive vocabulary. The EVT-3 provides standard scores for individuals ages 2.6 through 90 years.
Study NCT05312177 — intervention group
Intervention type: OTHER
Intervention: Leiter International Performance Scale, Third Edition
Description: The Leiter-3 is a nonverbal measure of cognitive functioning and fluid reasoning skills in individuals ages 3 through 75 years. The Leiter-3 measures nonverbal IQ across four subscales, including Sequential Order (SO), Form Completion (FC), Classification and Analogies (CA), and Figure Ground (FG).
Study NCT05312177 — intervention group
Intervention type: OTHER
Intervention: Social Communication Questionnaire, Current Form
Description: The SCQ is a parent-report measure of social communication, social interactions, play, and behavior.
Study NCT05312177 — intervention group
Intervention type: OTHER
Intervention: Aberrant Behavior Checklist
Description: The ABC-2 is a parent report measure of problematic behavior at home and in the community. It measures behavior on five subscales (1) Irritability, (2) Social Withdrawal, (3) Stereotypic Behavior, (4) Hyperactivity/Noncompliance, and (5) Inappropriate Speech.
Study NCT05312177 — intervention group
Intervention type: OTHER
Intervention: Repetitive Behavior Scale, Revised
Description: The RBS-R is a parent report measure that comprehensively surveys for the presence of repetitive behaviors.
Study NCT06153875 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Sensory Thresold, Burst High Frecuency
Description: The ultrasound guided percutaneous peripheral nerve stimulation will be applied to the Spinal or Inferior Gluteal and Tibial Nerve. The parameters will be 5 trains of 5 seconds, 55 seconds apart, at a frequency of 100Hz, making 5 minutes of total treatment. The intensity will be set 200 microamperes (μA) above the detection threshold for each patient, guaranteeing a sensitive but not painful perception.
Study NCT06153875 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Theta-Burst Stimulation
Description: The ultrasound guided percutaneous peripheral nerve stimulation will be applied to the Spinal or Inferior Gluteal and Tibial Nerve. The parameters will be 40 trains separated by 7 seconds from each other, where each train contains 5 trains separated by 200ms, at a frequency of 5Hz, resulting in 6 minutes and 45 seconds of total treatment. The intensity will be set at the motor threshold of the patient, ensuring a non-painful stimulation.
Study NCT06153875 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Transcutaneous Electrical Nerve Stimulation
Description: The transcutaneous electrical nerve stimulation will be applied on the trapezius or low back and internal calf muscles at a frequency of 80Hz and a pulse width of 250 microseconds, for 15 minutes. The intensity will be set at the detection threshold of each patient generating a sensitive but non-painful perception.
Study NCT05917561 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Anifrolumab Infusion Product
Description: Anifrolumab 300mg/month infusion for 36 weeks
Study NCT05917561 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo once a month, infusion for 36 weeks
Study NCT05177120 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Central Sensitization Inventory
Description: Standardized questionnaire to determine the level of central sensitization
Study NCT05177120 — intervention group
Intervention type: OTHER
Intervention: Short form-36
Description: Standardized questionnaire to investigate the quality of life in patients
Study NCT05177120 — intervention group
Intervention type: OTHER
Intervention: Pittsburgh Sleep Quality Index
Description: Standardized questionnaire to investigate the sleep quality and disturbance
Study NCT05177120 — intervention group
Intervention type: OTHER
Intervention: Health assessment questionnaire
Description: Standardized questionnaire used to detect the presence of disability
Study NCT05177120 — intervention group
Intervention type: OTHER
Intervention: Hospital anxiety and depression scale
Description: Standardized questionnaire to investigate the depression and anxiety
Study NCT05177120 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Fibromyalgia rapid screening tool
Description: Standardized questionnaire to determine the presence of fibromyalgia
Study NCT05177120 — intervention group
Intervention type: OTHER
Intervention: Familial Mediterranean Fever Quality of life scale
Description: Standardized questionnaire to investigate the quality of life in Familial Mediterranean Fever patients
Study NCT06478069 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Group A
Description: Group A was treated with Ibuprofen Dosage After breakfast and after dinner for 6 weeks.
Study NCT06478069 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Group B
Description: Group B was treated with physical therapy; (Upper limb: The stroke patient warmed up with some gentle stretches for the wrist and fingers to get the muscles ready. They subsequently engaged in resistance training using dumbbells or resistance bands to increase the strength of their upper limbs. Bicep curls, tricep extensions, and shoulder presses were some of these exercises. They tried to complete two to three sets of ten to fifteen repetitions for each exercise, progressively increasing the resistance as their strength increased. Then, to improve dexterity and coordination in daily tasks, functional exercises were included.
Study NCT04404387 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Administration of vitamin C
Description: The intervention is intravenous vitamin C administered in bolus doses of 50 mg/kg mixed in a 50-mL solution of either dextrose 5% in water (D5W) or normal saline (0.9% NaCl), during 30 to 60 minutes or more for participants over 120 kg not to exceed 100 mg/minute, every 6 hours for 96 hours (i.e. 200 mg/kg/day and 16 doses in total).~The other name of the drug: Ascorbic acid.
Study NCT04404387 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Administration of placebo
Description: Administration of placebo. Patients (in the control arm) will receive dextrose 5% in water (D5W) or normal saline (0.9% NaCl) in a volume to match the vitamin C. Placebo will be infused over 30 to 60 minutes or more for participants over 120 kg not to exceed 100 mg/minute as per the infusion instructions of vitamin C.
Study NCT05597085 — intervention group
Intervention type: DRUG
Intervention: Inotuzumab Ozogamicin
Description: Inotuzumab Ozogamicin is an Antibody drug conjugate directed against CD 22 positive B Cell ALL
Study NCT05070975 — intervention group
Intervention type: OTHER
Intervention: Epidemiology
Description: Assessment of the discrepancy of clinical severity of RSV-infections between twin infants.
Study NCT05762380 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Ferrous sulfate
Description: 2 FeSO4 supplements containing 27 mg elemental iron/supplements (54 mg total iron)
Study NCT05762380 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Ferrous sulfate-enriched Aspergillus oryzae (Ao iron)
Description: 2 Ao iron supplements containing 27 mg elemental iron/supplements (54 mg total iron)
Study NCT04327583 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: IPPACTTO
Description: The coordinated experimental pharmaceutical path consists of 7 pharmaceutical interviews or consultations. One initial pharmaceutical consultation with the hospital pharmacist. Five follow-up pharmaceutical interviews with the dispensary pharmacist. One follow-up pharmaceutical consultation with hospital pharmacist.~Each pharmaceutical interview or consultation will result in the drafting of a pharmaceutical report to be sent to the other participating health professionals. At each pharmaceutical consultation or interview, the pharmacists requested perform a clinical pharmaceutical analysis of drug prescriptions; Evaluate the patient's understanding; Detect adherence problems, Identify drug related problems; Alert the oncologist and / or the attending physician.
Study NCT04688736 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: The tablet resembles chlorpheniramine but has no therapeutic value.
Study NCT04688736 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Chlorpheniramine
Description: An antihistamine that reduces the natural chemical histamine in the body.
Study NCT05354583 — intervention group
Intervention type: DRUG
Intervention: Appropriate treatment
Description: Treatment with at least 3 antibiotics, which the pathogen is susceptible to based on in vitro drug susceptibility test, in the initial phase of the treatment
Study NCT04426877 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Experimental group
Description: The self-applied online program will comprise a three months behavioural intervention composed by 9 modules seeking to develop gradually achieving the goals of changing eating and physical activity habits, supported by audiovisual instructions. This group will receive access to the web-based lifestyle intervention (exercise and nutritional education), supported by audiovisual instructions given by their hypertension specialist doctor.
Study NCT04426877 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Control group
Description: The self-applied online program will comprise a three months behavioural intervention composed by 9 modules seeking to develop gradually achieving the goals of changing eating and physical activity habits, supported by audiovisual instructions. This group will receive the same web-based lifestyle intervention (exercise and nutritional education), but in this case supported by audiovisual instructions given by a doctor outside the patient.
Study NCT04647591 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Questionnaires
Description: Use of a questionnaire focused on diver experience and medical history upon inclusion and another questionnaire in case of ENT Barautrauma over a period of two years to standardize Barotrauma assessment.
Study NCT01870102 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Pelubiprofen IR (Pelubiprofen 30mg) TID
Study NCT01870102 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pelubiprofen SR (Pelubiprofen 45 mg) BID
Study NCT01870102 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Pelubiprofen SR (Pelubiprofen 45 mg) BID
Study NCT04712110 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: TAK-019
Description: TAK-019 intramuscular injection
Study NCT04712110 — intervention group
Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo intramuscular injection
Study NCT05931237 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Cranberry extract capsules
Description: Cranberry extract capsules (Prebiocran(TM))
Study NCT04512040 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: At-Home Yoga
Description: At-home yoga practice over 12 weeks.
Study NCT06464250 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Bundla care group
Description: A care package consisting of foot examination, correct foot care behaviours, and regular blood glucose monitoring was used.
Study NCT04459182 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: ENDOPAT
Description: digital plethysmography
Study NCT04459182 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: SHAM_COMPARATOR
Intervention: ENDOPAT
Description: digital plethysmography
Study NCT04866693 — intervention group
Intervention type: OTHER
Intervention: None - this is an exploratory qualitative study to understand patient safety problems in community-based mental healthcare.
Description: Qualitative study
Study NCT04858230 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: LymphoPilot
Description: LymphoPilot is an investigational medical device composed of an implanted part (pump, drainage catheter and output catheter), implanted in the subcutaneous tissue of the arm or of the leg and draining excess fluids to the supraclavicular or abdominal subcutaneous tissue, where fluids are naturally reabsorbed by the healthy lymphatic and venous system. The implanted part is activated and controlled via a wearable device.~The subcutaneous implantation of the device is performed in loco-regional or general anesthesia, in ambulatorial settings, and the patient is dismissed from the hospital on the same day of the procedure.~Patients will wear the external controller continuously throughout the study, except 30 minutes per day, to allow taking a shower/bath. The implanted device will be removed with a surgical procedure in local anesthesia 8 weeks after device implantation.